Serum visfatin level in prediabetics and its relation to left ventricular function
Introduction Visfatin is a molecule of clinical relevance, released mainly from visceral fat (hence it named as such) and could be a promising biomarker with diagnostic and prognostic significance in metabolic syndrome. Very little is known about visfatin and its relation with prediabetes. Objective...
Saved in:
Main Authors: | Mohammed Abdel-Hassib (Author), Abdelhaleem A Hassabo (Author), Hossam Elashmawy (Author), Mostafa I.S Mansour (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left ventricular myocardial performance index in prediabetic patients without coronary artery disease
by: Hossam Eldin M. Mahmoud, et al.
Published: (2021) -
Serum visfatin in type 2 diabetes mellitus
by: Samiha A. Abd Rabo, et al.
Published: (2013) -
Association of serum visfatin and its mRNA expression levels with cognitive function and idiopathic intracranial hypertension in obese Egyptian women
by: Nearmeen M Rashad, et al.
Published: (2019) -
Serum visfatin in chronic renal failure patients on maintenance hemodialysis: A correlation study
by: Abdel Wahab M Lotfy, et al.
Published: (2013) -
The impact of obesity on left ventricular mass and left ventricular systolic function in children
by: Ria Nova, et al.
Published: (2016)